Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI

References

1. 1.↵
   1. Fodoulian L,
   2. Tuberosa J,
   3. Rossier D, et al

   . SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. bioRxiv 2020. https://www.biorxiv.org/content/10.1101/2020.03.31.013268v1. Accessed May 12, 2020
2. 2.
   1. Desforges M,
   2. Le Coupanec A,
   3. Dubeau P, et al

   . Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12:14 doi:10.3390/v12010014 pmid:31861926

   CrossRefPubMed
3. 3.↵
   1. Morris M,
   2. Zohrabian VM

   . Neuroradiologists, be mindful of the neuroinvasive potential of COVID-19. AJNR Am J Neuroradiol 2020 Apr 30. [Epub ahead of print] doi:10.3174/ajnr.A6551 pmid:32354715

   FREE Full Text
4. 4.↵
   1. Montalvan V,
   2. Lee J,
   3. Bueso T, et al

   . Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 2020;194:10592 doi:10.1016/j.clineuro.2020.105921 pmid:32422545

   CrossRefPubMed
5. 5.↵
   1. Whittaker A,
   2. Anson M,
   3. Harky A

   . Neurological Manifestations of COVID-19: A review. Acta Neurol Scand 2020;142:14–22 doi:10.1111/ane.13266 pmid:32412088

   CrossRefPubMed
6. 6.↵
   1. Ahmad I,
   2. Rathore FA

   . Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 2020 May 6. [Epub ahead of print] doi:10.1016/j.jocn.2020.05.017 pmid:32409215

   CrossRefPubMed
7. 7.↵
   1. Asadi-Pooya AA,
   2. Simani L

   . Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 2020;413:116832 doi:10.1016/j.jns.2020.116832 pmid:32299017

   CrossRefPubMed
8. 8.↵
   1. Goldberg MF,
   2. Cerejo R,
   3. Tayal AH

   . Cerebrovascular disease in COVID-19. AJNR Am J Neuroradiol 2020 May 14. [Epub ahead of print] doi:10.3174/ajnr.A6588 pmid:32409316

   CrossRefPubMed
9. 9.↵
   1. Aggarwal G,
   2. Lippi G,
   3. Michael Henry B

   . Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 2020;15:385–89 doi:10.1177/1747493020921664 pmid:32310015

   CrossRefPubMed
10. 10.↵
    1. Poyiadji N,
    2. Shahin G,
    3. Noujaim D, et al

    . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 March 31. [Epub ahead of print] doi:10.1148/radiol.2020201187 pmid:32228363

    CrossRefPubMed
11. 11.↵
    1. Franceschi AM,
    2. Ahmed O,
    3. Giliberto L, et al

    . Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol 2020 May 21. [Epub ahead of print] doi:10.3174/ajnr.A6595 pmid:32439646

    CrossRefPubMed
12. 12.↵
    1. Poillon G,
    2. Obadia M,
    3. Perrin M, et al

    . Cerebral venous thrombosis associated with COVID-19 infection: causality or coincidence? J Neuroradiol 2020 May 10. [Epub ahead of print] doi:10.1016/j.neurad.2020.05.003 pmid:32437707

    CrossRefPubMed
13. 13.↵
    1. Garaci F,
    2. Di Giuliano F,
    3. Picchi E, et al

    . Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci 2020;414:116871 doi:10.1016/j.jns.2020.116871 pmid:32422428

    CrossRefPubMed
14. 14.↵
    1. Hughes C,
    2. Nichols T,
    3. Pike M, et al

    . Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 2020;7:001691 doi:10.12890/2020_001691 pmid:32399457

    CrossRefPubMed
15. 15.↵
    1. Radmanesh A,
    2. Derman A,
    3. Lui YW, et al

    . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020202040 pmid:32437314

    CrossRefPubMed
16. 16.↵
    1. Mahammedi A,
    2. Saba L,
    3. Vagal A, et al

    . Imaging in neurological disease of hospitalized COVID-19 patients: an Italian multicenter retrospective observational study. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020201933 pmid:32437313

    CrossRefPubMed
17. 17.↵
    1. Karimi-Galougahi M,
    2. Yousefi-Koma A,
    3. Bakhshayeshkaram M, et al

    . ¹⁸FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol 2020 May 3. [Epub ahead of print] doi:10.1016/j.acra.2020.04.030 pmid:32386948

    CrossRefPubMed
18. 18.↵
    1. Laurendon T,
    2. Radulesco T,
    3. Mugnier J, et al

    . Bilateral transient olfactory bulbs edema during COVID-19-related anosmia. Neurology 2020 May 22. [Epub ahead of print] doi:10.1212/WNL.0000000000009850 pmid:32444492

    CrossRefPubMed
19. 19.↵
    1. Weiss P,
    2. Murdoch DR

    . Clinical course and mortality risk of severe COVID-19. Lancet 2020;395:1014–15 doi:10.1016/S0140-6736(20)30633-4 pmid:32197108

    CrossRefPubMed
20. 20.↵
    1. Zhou F,
    2. Yu T,
    3. Du R, et al

    . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62 doi:10.1016/S0140-6736(20)30566-3 pmid:32192581

    CrossRefPubMed
21. 21.↵
    1. Hopkins C,
    2. Surda P,
    3. Whitehead E, et al

    . Early recovery following new onset anosmia during the COVID-19 pandemic: an observational cohort study. J Otolaryngol Head Neck Surg 2020;49:26 doi:10.1186/s40463-020-00423-8 pmid:32366299

    CrossRefPubMed
22. 22.
    1. Kaye R,
    2. Chang CW,
    3. Kazahaya K, et al

    . Anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg 2020 Apr 28. [Epub ahead of print] doi:10.1177/0194599820922992 pmid:32340555

    CrossRefPubMed
23. 23.
    1. Gane SB,
    2. Kelly C,
    3. Hopkins C

    . Isolated sudden onset anosmia in COVID-19 infection: a novel syndrome? Rhinology 2020;58:299–301 doi:10.4193/Rhin20.114] pmid:32240279

    CrossRefPubMed
24. 24.
    1. Ghiasvand F,
    2. SeyedAlinaghi S

    . Isolated anosmia as a presentation of COVID-19: an experience in a referral hospital. Infect Disord Drug Targets 2020 May 20. [Epub ahead of print] doi:10.2174/1871526520999200520173216 pmid:32436835

    CrossRefPubMed
25. 25.
    1. Heidari F,
    2. Karimi E,
    3. Firouzifar M, et al

    . Anosmia as a prominent symptom of COVID-19 infection. Rhinology 2020;58:302–03 doi:10.4193/Rhin20.140 pmid:32319971

    CrossRefPubMed
26. 26.
    1. Lechien JR,
    2. Barillari MR,
    3. Jouffe L, et al

    . Anosmia Is a key symptom of COVID-19 infection and should be used as a diagnostic tool. Ear Nose Throat J 2020 May 21. [Epub ahead of print] doi:10.1177/0145561320925191 pmid:32436441

    CrossRefPubMed
27. 27.
    1. Villalba NL,
    2. Maouche Y,
    3. Ortiz MB, et al

    . Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Intern Med 2020;7:001641 doi:10.12890/2020_001641 pmid:32309267

    CrossRefPubMed
28. 28.↵
    1. Marinosci A,
    2. Landis BN,
    3. Calmy A

    . Possible link between anosmia and COVID-19: sniffing out the truth. Eur Arch Otorhinolaryngol 2020 Apr 17. [Epub ahead of print] doi:10.1007/s00405-020-05966-0 pmid:32303881

    CrossRefPubMed
29. 29.↵
    1. Vaira LA,
    2. Salzano G,
    3. Fois AG, et al

    . Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol 2020 Apr 27. [Epub ahead of print] doi:10.1002/alr.22593 pmid:32342636

    CrossRefPubMed
30. 30.↵
    1. van Riel D,
    2. Verdijk R,
    3. Kuiken T

    . The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 2015;235:277–87 doi:10.1002/path.4461 pmid:25294743

    CrossRefPubMed
31. 31.↵
    1. Eliezer M,
    2. Hautefort C,
    3. Hamel AL, et al

    . Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg 2020 Apr 8. [Epub ahead of print] doi:10.1001/jamaoto.2020.0832 pmid:32267483

    CrossRefPubMed
32. 32.↵
    1. Netland J,
    2. Meyerholz DK,
    3. Moore S, et al

    . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264–75 doi:10.1128/JVI.00737-08 pmid:18495771

    Abstract/FREE Full Text